Sangam Shah, MBBS

Articles by Sangam Shah, MBBS

Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review

BySangam Shah, MBBS,Rukesh Yadav, MBBS,Abhinav Bhattarai, BSc,Sunraj Tharu, BSc,Prakash Sharma, MBBS,Prativa Subedi, MBBS,Arun Kharel, MBBS,Pitambar Khanal, MBBS,Pradeep Khanal, MBBS, MD,Sri Kollepara, MD,Krishna Gundabolu, MBBS, MS

December 18th 2023

Danazol was reviewed as an effective treatment option for patients with myelodyspplastic syndromes, according to a recently published article by Sangam Shah, MBBS, et al.

Latest Updated Articles

Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review
Published: December 18th 2023 | Updated:

Sangam Shah, MBBS

Articles by Sangam Shah, MBBS

Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

FDA Approves Revumenib in R/R NPM1-Mutant AML

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment

HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma